News
Immune checkpoint pathways regulate T cell function and play pivotal roles in the treatment of both cancer and autoimmune ...
CAMPATH-1, an antibody to human lymphocytes (antibody to CD52) now commercially available as alemtuzumab, emerged from that line of thinking 10.
The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...
During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...
The FDA granted accelerated approval of linvoseltamab-gcpt for certain patients with multiple myeloma.Specifically, the ...
6don MSN
Immutep Limited (NASDAQ:IMMP) is one of the 7 Best ASX Stocks to Buy Now. On June 23, Immutep Limited (NASDAQ:IMMP) announced ...
A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...
Insects possess a remarkable ability to develop innate immune memory, and the mechanisms underlying this process are becoming a central topic in innate immunity research.
Several experts are seeing that value of AI's total overhaul of healthcare, including beneficial additions such as generative ...
3d
MedPage Today on MSNNew Bispecific T-Cell Engager Approved for Multiple MyelomaA B-cell maturation antigen (BCMA)-directed bispecific antibody, linvoseltamab is indicated for adult patients who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results